Anavex Life Sciences Corp. (LON:0HFR)
London · Delayed Price · Currency is GBP · Price in USD 11.08
+0.03 (0.27%)
At close: Jul 11, 2025
Anavex Life Sciences Market Cap
Anavex Life Sciences has a market cap or net worth of 692.88 million as of July 16, 2025. Its market cap has increased by 141.29% in one year.
Market Cap
692.88M
Enterprise Value
606.44M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
11.08
Market Cap Chart
Since April 13, 2006, Anavex Life Sciences's market cap has increased from 182.56K to 692.88M, an increase of 379,437.35%. That is a compound annual growth rate of 53.38%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 165.33B |
| GSK plc | 57.64B |
| Haleon | 32.99B |
| Smith & Nephew | 9.79B |
| ConvaTec Group | 5.29B |
| Hikma Pharmaceuticals | 4.35B |
| HUTCHMED (China) | 2.04B |
| Genus | 1.47B |